Literature DB >> 23271789

Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging.

Piotr Musialek1, Lukasz Tekieli, Magdalena Kostkiewicz, Tomasz Miszalski-Jamka, Piotr Klimeczek, Wojciech Mazur, Wojciech Szot, Marcin Majka, R Pawel Banys, Danuta Jarocha, Zbigniew Walter, Maciej Krupinski, Piotr Pieniazek, Maria Olszowska, Krzysztof Zmudka, Mieczyslaw Pasowicz, Dean J Kereiakes, Wieslawa Tracz, Piotr Podolec, Wojciech Wojakowski.   

Abstract

BACKGROUND: Effective progenitor cell recruitment to the ischemic injury zone is a prerequisite for any potential therapeutic effect. Cell uptake determinants in humans with recent myocardial infarction are not defined. We tested the hypothesis that myocardial uptake of autologous CD34(+) cells delivered via an intracoronary route after recent myocardial infarction is related to left ventricular (LV) ejection fraction (LVEF) and infarct size. METHODS AND
RESULTS: Thirty-one subjects (age, 36-69 years; 28 men) with primary percutaneous coronary intervention-treated anterior ST-segment-elevation myocardial infarction and significant myocardial injury (median peak troponin I, 138 ng/dL [limits, 58-356 ng/dL]) and sustained LVEF depression at ≤45% were recruited. On day 10 (days 7-12), 4.3×10(6) (0.7-9.9×10(6)) (99m)Tc-extametazime-labeled autologous bone marrow CD34(+) cells (activity, 77 MBq [45.9-86.7 MBq]) were administered transcoronarily (left anterior descending coronary artery). (99m)Tc-methoxyisobutyl isonitrile (99(m)Tc-MIBI) single-photon emission computed tomography before cell delivery showed 7 (2-11) (of 17) segments with definitely abnormal/absent perfusion. Late gadolinium-enhanced infarct core mass was 21.7 g (4.4-45.9 g), and infarct border zone mass was 29.8 g (3.9-60.2 g) (full-width at half-maximum, signal intensity thresholding algorithm). One hour after administration, 5.2% (1.7%-9.9%) of labeled cell activity localized in the myocardium (whole-body planar γ scan). Image fusion of labeled cell single-photon emission computed tomography with LV perfusion single-photon emission computed tomography or with cardiac magnetic resonance infarct imaging indicated cell uptake in the peri-infarct zone. Myocardial uptake of labeled cells activity correlated in particular with late gadolinium-enhanced infarct border zone mass (r=0.84, P<0.0001) and with peak troponin I (r=0.76, P<0.001); it also correlated with severely abnormal/absent perfusion segment number (r=0.45, P=0.008) and late gadolinium-enhanced infarct core (r=0.58 and r=0.84, P<0.0001) but not with echocardiography LVEF (r=-0.07, P=0.68) or gated single-photon emission computed tomography LVEF (r=-0.28, P=0.16). The correlation with cardiac magnetic resonance imaging-LVEF was weak (r=-0.38; P=0.04).
CONCLUSIONS: This largest human study with labeled bone marrow CD34(+) cell transcoronary transplantation after recent ST-segment-elevation myocardial infarction found that myocardial cell uptake is determined by infarct size rather than LVEF and occurs preferentially in the peri-infarct zone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271789     DOI: 10.1161/CIRCIMAGING.112.979633

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  13 in total

1.  Fluorine-19 Labeling of Stromal Vascular Fraction Cells for Clinical Imaging Applications.

Authors:  Laura C Rose; Deepak K Kadayakkara; Guan Wang; Amnon Bar-Shir; Brooke M Helfer; Charles F O'Hanlon; Dara L Kraitchman; Ricardo L Rodriguez; Jeff W M Bulte
Journal:  Stem Cells Transl Med       Date:  2015-10-28       Impact factor: 6.940

Review 2.  Tracking gene and cell fate for therapeutic gain.

Authors:  Nigel G Kooreman; Julia D Ransohoff; Joseph C Wu
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

3.  Circulating exosomes derived from transplanted progenitor cells aid the functional recovery of ischemic myocardium.

Authors:  Progyaparamita Saha; Sudhish Sharma; Laxminarayana Korutla; Srinivasa Raju Datla; Farnaz Shoja-Taheri; Rachana Mishra; Grace E Bigham; Malini Sarkar; David Morales; Gregory Bittle; Muthukumar Gunasekaran; Chetan Ambastha; Mir Yasir Arfat; Deqiang Li; Andreas Habertheuer; Robert Hu; Manu O Platt; Peixin Yang; Michael E Davis; Prashanth Vallabhajosyula; Sunjay Kaushal
Journal:  Sci Transl Med       Date:  2019-05-22       Impact factor: 17.956

4.  Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study.

Authors:  Piotr Musialek; Adam Mazurek; Danuta Jarocha; Lukasz Tekieli; Wojciech Szot; Magdalena Kostkiewicz; R Pawel Banys; Malgorzata Urbanczyk; Andrzej Kadzielski; Mariusz Trystula; Jacek Kijowski; Krzysztof Zmudka; Piotr Podolec; Marcin Majka
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-06-22       Impact factor: 1.426

5.  Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration.

Authors:  Marek Malecki; Chelsea Sabo; Emily Putzer; Chris Stampe; Afsoon Foorohar; Carol Quach; Michael Beauchaine; Xenia Tombokan; Mark Anderson
Journal:  Mol Cell Ther       Date:  2013-12-13

6.  Time course of VCAM-1 expression in reperfused myocardial infarction in swine and its relation to retention of intracoronary administered bone marrow-derived mononuclear cells.

Authors:  André Uitterdijk; Bianca C W Groenendijk; Charlotte Gorsse-Bakker; Anna Panasewicz; Stefan Sneep; Dennie Tempel; Esther H van de Kamp; Daphne Merkus; Willem J van der Giessen; Dirk J Duncker
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

7.  Suggested indications of clinical practice guideline for stem cell-therapy in cardiovascular diseases: A stepwise appropriate use criteria for regeneration therapy.

Authors:  Mohaddeseh Behjati
Journal:  ARYA Atheroscler       Date:  2013-09

Review 8.  In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine.

Authors:  Mayra Lorena Moreira; Priscylla da Costa Medeiros; Sergio Augusto Lopes de Souza; Bianca Gutfilen; Paulo Henrique Rosado-de-Castro
Journal:  Stem Cells Int       Date:  2016-01-12       Impact factor: 5.443

9.  Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells.

Authors:  Christina L O'Neill; Jasenka Guduric-Fuchs; Sarah E J Chambers; Michelle O'Doherty; Barbara Bottazzi; Alan W Stitt; Reinhold J Medina
Journal:  Cardiovasc Res       Date:  2016-09-22       Impact factor: 10.787

10.  Temporal changes in the pattern of invasive angiography use and its outcome in suspected coronary artery disease: implications for patient management and healthcare resources utilization.

Authors:  Jakub Chmiel; Miłosz K Książek; Weronika Stryszak; Paweł Iwaszczuk; Mateusz K Hołda; Grażyna Świtacz; Artur Kozanecki; Piotr Wilkołek; Paweł Rubiś; Grzegorz Kopeć; Piotr Odrowąż-Pieniążek; Tadeusz Przewłocki; Wiesława Tracz; Piotr Podolec; Piotr Musiałek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-09-21       Impact factor: 1.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.